Alychlo — 2019 Investments

1 investments dated 2019 · listed companies and verified rows first · show all

Sophia Geneticssophiagenetics.com in 𝕏Jan 2019 · $77M

SOPHiA GENETICS develops the SOPHiA DDM data analytics platform for genomic and multimodal data analysis, offering solutions used in oncology research and in vitro diagnostics.

AI & Machine LearningBiotechDigital HealthMedical Devices

Co-investors360 Capital aMoon Balderton Capital Compound Hitachi Ventures ACE & Company +2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.